REGN : Analysis & Opinions

  1. ETF Analysis: iShares NASDAQ Biotechnology

    August 7, 2015
    Learn about the iShares Nasdaq Biotechnology exchange-traded fund, which offers one of the most diversified ways of investing ...
  2. Is Amgen About to Enter a Battle Over Billions?

    June 15, 2015
    The Food and Drug Administration's key advisory committee has given the thumbs-up to two new drugs belonging to an entirely ...
  3. Amgen Gets 1 Step Closer to Another Blockbuster

    May 26, 2015
    A key European advisory committee has just thrown its support behind approval for Amgen's (NASDAQ: AMGN) Repatha, a new ...
  4. The Biggest Biotech Companies

    January 15, 2015
    These biotech firms want to revolutionize medicine. If successful, they may see high profits, but investing in these companies ...
  5. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    November 12, 2013
    Among leading biotech and emerging pharmaceutical companies, the number of shares sold short in Alexion Pharmaceuticals ...
  6. Market Wrap: Stocks End Flat, but Tesla Shares Sag After Hours

    November 5, 2013
    Stocks ended Tuesday basically flat, as investors started to focus on economic realities. But the market could see some ...
  7. Biotechnology: Some of the Strongest Stocks on Nearly Any Time ...

    September 18, 2013
    Biotechnology is an industry which as has lead the very strong healthcare sector on almost every time frame over the last ...
  8. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, ...

    September 14, 2013
    Declining short interest in Alexion Pharmaceuticals (NASDAQ: PCYC) bucked the trend among leading biotech and emerging pharmaceutical ...
  9. Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, ...

    June 26, 2013
    Among biotech and emerging pharmaceutical companies, Celgene (NASDAQ: CELG) and saw the most significant rise in short interest ...
  10. Regeneron Pharmaceuticals Among Healthcare's Biggest Movers on ...

    November 30, 2012
    This morning's trading has marked a bad day for the market so far. The Nasdaq has decreased 0.4%; the S&P 500 has slipped ...
  11. Regeneron Pharmaceuticals and More Big Movers on the Nasdaq on ...

    November 16, 2012
    The market has been slipping so far today: the Nasdaq is trading down 1%; the S&P 500 is down 0.6%; and the Dow has slipped ...
  12. Fresenius Medical Care AG & Co and Other Big Movers In Healthcare ...

    November 1, 2012
    The Nasdaq has moved up 1.5%, the S&P 500 is trading up 1.1% and the Dow has risen 1.1%, marking a bad morning for the ...
  13. Healthcare Stocks, Including Gilead, Making Big Moves on October ...

    October 24, 2012
    So far today, the Nasdaq remains relatively unchanged, the S&P 500 has risen 0.1% and the Dow has climbed 0.3%. The healthcare ...
  14. Biotech Stocks With Bullish Trends From Short Sellers

    March 26, 2012
    One of the clearest sentiment indicators comes from short sellers. Changes in the number of shares shorted over time can ...
  15. 4 Overbought Stocks To Watch

    January 16, 2012
    Stocks with an RSI reading over 80
  16. Sanofi's Investment Prospects

    December 21, 2011
    Sanofi has emerged as an unheralded value in pharmaceuticals.
  17. XOMA Rearranges The Deck Chairs One More Time

    September 2, 2011
    XOMA changes management again, but should anybody care?
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!